Comparing low-risk PCa patients (n = 141) to intermediate- and high-risk PCa patients (n = 135), there were no significant differences in the baseline characteristics age (71.8 vs. 73.0 years; p = 0.22), BMI (26.5 vs. 26.8 kg/m2; p = 0.70), measured prostate volume (65.8 vs. 61.7 cc; p = 0.38) and PSA (6.2 vs. 8.7 ng/mL; p = 0.61). The gene discussed is KLK3; the disease is posterior cortical atrophy.